FIELD: medicine. SUBSTANCE: method involves applying ophthalmic drops instillation using drops containing glycosamine glycanes which concentration varies from 0.35% to 1.0% with various combinations of their particular classes like hyaluronic acid, chodroitin-4-sulfate, chodroitin-6-sulfate, heparan sulfate, keratan sulfate. EFFECT: stimulated regeneration of corneal optical properties; improved vision function. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC DROP | 1999 |
|
RU2163123C2 |
| EXPERIMENTAL METHOD FOR TREATING PROGRESSING MYOPIA | 2000 |
|
RU2194478C2 |
| OPHTHALMIC DROPS | 2002 |
|
RU2216331C1 |
| EYE DROPS | 1994 |
|
RU2088215C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES AND EYE CORNEA INJURIES | 2004 |
|
RU2259833C1 |
| OPHTHALMIC DROPS "INTERPAN" | 2001 |
|
RU2196588C1 |
| METHOD FOR PREPARING BRAIN TISSUE FOR DETERMINING GLYCOSAMINEGLYCANES | 1999 |
|
RU2152027C1 |
| PHARMACOLOGICALLY ACTIVE SUBSTANCE FOR OPHTHALMOLOGY | 2004 |
|
RU2272635C1 |
| OPHTHALMIC DROPS | 2000 |
|
RU2171107C1 |
| SOLUTION FOR PROTECTION OF CORNEA AGAINST INJURY | 2006 |
|
RU2310440C1 |
Authors
Dates
2002-03-27—Published
1999-07-15—Filed